Clinical calculator summary
Original 2015 New England Spinal Metastasis Score
Clinical calculator summary
Original 2015 New England Spinal Metastasis Score
A capped 0-3 prognostic score combining modified Bauer, independent ambulation, and serum albumin.
Evidence-based context for fast calculator use
- Purpose:
- Reproduce the original NESMS arithmetic for baseline spinal metastatic disease assessment.
- Population:
- Confirmed metastatic disease involving the spine; original derivation cohort was operative.
- Factors:
- Modified Bauer score, Independent ambulation, Serum albumin >=3.5 g/dL
- Reference:
- Ghori AK, et al. Spine J. 2015. DOI: 10.1016/j.spinee.2015.06.061.
New England Spinal Metastasis Score (NESMS)
Clinical Context & Background
Modified Bauer = primary points (lung 0; other non-lung 1; breast/kidney/lymphoma/myeloma 2) + 1 for no visceral metastases + 1 for a solitary skeletal metastasis. Modified Bauer >=3 contributes 2 NESMS points; independent ambulation contributes 1; albumin >=3.5 g/dL contributes 1. NESMS = min(3, component sum).Reference Data
| NESMS | Prospective-validation one-year mortality | Prospective-validation one-year survival |
|---|---|---|
| 0 | 100% | 0% |
| 1 | 78% | 22% |
| 2 | 48% | 52% |
| 3 | 15% | 85% |
Clinical Workflow
Use, Interpret, And Continue The Patient Pathway
Expand for workflow guidance, limitations, examples, and related next steps.
Clinical Workflow
Use, Interpret, And Continue The Patient Pathway
Expand for workflow guidance, limitations, examples, and related next steps.
When To Use
- At baseline before treatment for confirmed metastatic disease involving the spine.
- Use a raw serum albumin result and explicit source-defined clinical categories.
How To Interpret
- Modified Bauer 0-2 contributes zero NESMS points; 3-4 contributes two.
- Independent ambulation and albumin at least 3.5 g/dL each contribute one point; cap the total at 3.
- Displayed outcome percentages are unadjusted prospective-validation cohort observations, not individualized probabilities.
What To Do Next
- Document the assessment context, metastatic burden, visceral disease, ambulation, and albumin used.
- Interpret with oncology, spine-surgery, radiation-oncology, and palliative-care assessment as appropriate.
Limitations
- Original derivation was in surgical patients; baseline nonoperative use relies on later validation.
- Not for primary or benign spinal disease, skeletal metastases without spinal involvement, or post-treatment reassessment.
- The score does not independently determine treatment eligibility, modality, or goals of care.
Validated Population
Original operative cohort with metastatic spinal disease; later operative and nonoperative validation cohorts.
Ceiling example
Modified Bauer >=3, independent ambulation, and albumin >=3.5 produce an uncapped sum of 4; final NESMS is capped at 3.
Calculation verification history
Verified
Calculation verification history
Verified: Production browser revalidation
- Three source-backed NESMS cases passed through visible production controls at scores 0, 2, and capped 3.
- No unexpected N/A, literal undefined value, stale control, or browser-console error was observed.
Case-level evidence is retained in validation/browser-revalidation/nesms-epidural-spinal-cord-compression-2026-08-03.json.
: Production browser validation
- Ten source-backed cases were exercised on the public production route through visible browser controls; 10/10 case records passed their expected-versus-observed assertions across 11 visible submissions.
- Overall browser status: failed-console. medium: Production emitted minified React error #418 during route loads/reloads used by this run.
- Case-level inputs, expected and observed results, reset/repeat behavior, failure reproductions, and console evidence are retained in the production-browser evidence record.
Case-level production evidence is retained in validation/browser-production/nesms-epidural-spinal-cord-compression.json.
: Input workflow simplified and revalidated
- Reduced the public form to result-, branch-, unit-, and applicability-changing inputs; removed or consolidated non-scoring, administrative, and duplicate questions.
- Preserved the verified calculation or report-interpretation logic, thresholds, model version, component logic, and supported result pathways behind strict deterministic adapters.
- Passed the calculator-specific regression audit, adapter-parity and malformed-input checks, the 144-calculator input-quality audit, and the 43-calculator entry-burden audit.
: Full validation test
- 320/320 source-model, exhaustive valid-state, UI, boundary, malformed-input, applicability, trace, registry, report, history, and isolation checks passed.
- This verifies implementation of the selected historical model, not independent clinical validation, an individualized survival probability, or a treatment recommendation.
: Calculation and input-contract correction
- Corrected the modified Bauer contribution from 1 to 2 points and its threshold from at least 2 to at least 3; added the explicit three-point NESMS ceiling.
- Replaced pre-scored albumin and broad ambulation with raw albumin at the 3.5 g/dL boundary and independent ambulation only.
- Removed favorable defaults, permissive coercion, invented survival bands, and treatment-selection wording; added baseline disease and assessment-context gates.
Included in the current validation report.
Verification confirms the calculator implementation against the cited model; it is not independent clinical validation, regulatory approval, or medical advice.
Related Tools
Frequently Asked Questions
What does solitary metastasis mean in NESMS?
It means a solitary skeletal metastasis across the total skeletal burden, not simply a single involved spinal level.
Does dependent ambulation score a point?
No. Only independent ambulation contributes one NESMS point.
Can NESMS decide whether surgery should be performed?
No. It is a prognostic adjunct and does not independently select surgery or another treatment.
Evidence-based oncology decision support. Verify with clinical guidelines.